| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4504b4f2975481dd0a882e06fd62c72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 |
| filingDate |
2005-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2512d825733fa023c8ba1b23e2aea749 |
| publicationDate |
2005-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005123075-A2 |
| titleOfInvention |
Controlling angiogenesis with anabaseine analogs |
| abstract |
Compounds controlling angiogenesis and vasculogenesis. In particular, induction of angiogenesis to promote growth of new vasculature by the use of anabaseine agonists and to the reduction of pathological angiogenesis by the use of anabaseine antagonists. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8008499-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011094489-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014015217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7662965-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012054870-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007089626-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007089626-A3 |
| priorityDate |
2004-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |